Protara Therapeutics (TARA) Goodwill & Intangibles (2020 - 2022)
Protara Therapeutics (TARA) posted quarterly Goodwill & Intangibles of $29.5 million for Q3 2022, little changed year-over-year from $29.5 million in Q3 2021, and little changed quarter-over-quarter from $29.5 million in Q2 2022.
Analysis
Protara Therapeutics (TARA) Goodwill & Intangibles (2020 - 2022) Analysis & Trends
Protara Therapeutics (TARA) has reported Goodwill & Intangibles for 3 consecutive years, with $29.5 million the latest figure, recorded in Q3 2022.
- In Q3 2022, Goodwill & Intangibles changed 0.0% year-over-year to $29.5 million; the TTM figure through Sep 2022 stood at $29.5 million (changed 0.0% YoY), while the FY2021 annual figure was $29.5 million, changed 0.0% from the prior year.
- Goodwill & Intangibles was little changed at $29.5 million in Q3 2022 per TARA's latest filing, from $29.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $29.5 million in Q4 2020 and bottomed at $29.4 million in Q1 2020.
- Historically, Goodwill & Intangibles has averaged $29.5 million across 3 years, with a median of $29.5 million in 2020.
- On a YoY basis, Goodwill & Intangibles climbed as much as 0.51% in 2021 and fell as far as 0.0% in 2021.
- Protara Therapeutics' Goodwill & Intangibles stood at $29.5 million in 2020, then changed by 0.0% to $29.5 million in 2021, then changed by 0.0% to $29.5 million in 2022.
- Business Quant data shows TARA's Goodwill & Intangibles at $29.5 million in Q3 2022, $29.5 million in Q2 2022, and $29.5 million in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 29.52 Mn |
| Jun 30, 2022 | 29.52 Mn |
| Mar 31, 2022 | 29.52 Mn |
| Dec 31, 2021 | 29.52 Mn |
| Sep 30, 2021 | 29.52 Mn |
| Jun 30, 2021 | 29.52 Mn |
| Mar 31, 2021 | 29.52 Mn |
| Dec 31, 2020 | 29.52 Mn |
| Sep 30, 2020 | 29.37 Mn |
| Jun 30, 2020 | 29.37 Mn |
| Mar 31, 2020 | 29.37 Mn |